retatrutide clinical trials status Phase 3: TRIUMPH Program Results 2026 retatrutide clinical trial status retatrutide

Food and Drug Administration (FDA) for human use or medical application

Merrill, L

Multi Complete: 1 serving daily with food for foundational nutrition

[1] [3] This distinguishes semaglutide from some medications that may contribute to dry mouth, such as SGLT2 inhibitors (which can cause dehydration through increased urination) or anticholinergic medications (which directly reduce salivary flow)

GLP-1 medications have become one of the most talked-about treatments for weight management and type 2 diabetes

All cell lines tested negative for mycoplasma contamination using a MycoAlert Mycoplasma Detection kit (Lonza, LT07-418)